198 related articles for article (PubMed ID: 12843931)
1. [Steatohepatitis and metabolic and nutritional abnormalities].
Deugnier Y; Lainé F
Gastroenterol Clin Biol; 2003 May; 27(5 Suppl):B9-12. PubMed ID: 12843931
[No Abstract] [Full Text] [Related]
2. [NASH -- nonalcoholic steatohepatitis].
Blechacz B; Stremmel W
Z Gastroenterol; 2003 Jan; 41(1):77-90. PubMed ID: 12541180
[TBL] [Abstract][Full Text] [Related]
3. [Nonalcoholic steatohepatitis: diagnosis, pathogenesis, treatment and prognosis].
Jansen PL
Ned Tijdschr Geneeskd; 2005 Feb; 149(6):289-94. PubMed ID: 15730035
[TBL] [Abstract][Full Text] [Related]
4. [Role of lipid peroxidation in non-alcoholic steatohepatitis].
Fraenkel E; Lazúrová I; Fehér J
Orv Hetil; 2004 Mar; 145(12):611-8. PubMed ID: 15119115
[TBL] [Abstract][Full Text] [Related]
5. Diagnosis and therapy of nonalcoholic steatohepatitis.
Torres DM; Harrison SA
Gastroenterology; 2008 May; 134(6):1682-98. PubMed ID: 18471547
[TBL] [Abstract][Full Text] [Related]
6. [Nonalcoholic steatohepatitis].
Castellano Tortajada G
Gastroenterol Hepatol; 1999 Feb; 22 Suppl 1():13-9. PubMed ID: 10085596
[No Abstract] [Full Text] [Related]
7. [Nonalcoholic steatohepatitis: epidemiology, diagnosis and treatment].
Tilg H
Dtsch Med Wochenschr; 2001 Apr; 126(16):467-71. PubMed ID: 11360453
[No Abstract] [Full Text] [Related]
8. [Non-alcoholic steatohepatitis].
Petit P; Zarski JP
Gastroenterol Clin Biol; 2000 Feb; 24(2):157-9. PubMed ID: 12687955
[No Abstract] [Full Text] [Related]
9. Pediatric nonalcoholic fatty liver disease in 2009.
Alisi A; Manco M; Vania A; Nobili V
J Pediatr; 2009 Oct; 155(4):469-74. PubMed ID: 19772998
[No Abstract] [Full Text] [Related]
10. Insulin resistance and oxidative stress interdependency in non-alcoholic fatty liver disease.
Videla LA; Rodrigo R; Araya J; Poniachik J
Trends Mol Med; 2006 Dec; 12(12):555-8. PubMed ID: 17049925
[TBL] [Abstract][Full Text] [Related]
11. Nonalcoholic fatty liver disease and nonalcoholic steatohepatitis.
Harrison SA; Neuschwander-Tetri BA
Clin Liver Dis; 2004 Nov; 8(4):861-79, ix. PubMed ID: 15464659
[TBL] [Abstract][Full Text] [Related]
12. [Nonalcoholic steatohepatitis: pathogenesis and treatment].
Park SH
Korean J Hepatol; 2008 Mar; 14(1):12-27. PubMed ID: 18367854
[TBL] [Abstract][Full Text] [Related]
13. [Obesity and non-alcoholic steatohepatitis].
Méndez-Sánchez N; Chávez-Tapia NC; Uribe M
Gac Med Mex; 2004; 140 Suppl 2():S67-72. PubMed ID: 15641474
[TBL] [Abstract][Full Text] [Related]
14. Metabolic aspects of hepatitis C viral infection: steatohepatitis resembling but distinct from NASH.
Koike K; Moriya K
J Gastroenterol; 2005 Apr; 40(4):329-36. PubMed ID: 15868369
[TBL] [Abstract][Full Text] [Related]
15. Molecular mechanisms and therapeutic targets in steatosis and steatohepatitis.
Anderson N; Borlak J
Pharmacol Rev; 2008 Sep; 60(3):311-57. PubMed ID: 18922966
[TBL] [Abstract][Full Text] [Related]
16. Review article: the pathogenesis of fibrosis in non-alcoholic steatohepatitis.
Marra F; Aleffi S; Bertolani C; Petrai I; Vizzutti F
Aliment Pharmacol Ther; 2005 Nov; 22 Suppl 2():44-7. PubMed ID: 16225472
[TBL] [Abstract][Full Text] [Related]
17. Nonalcoholic fatty liver disease of obesity.
Sachdev MS; Riely CA; Madan AK
Obes Surg; 2006 Nov; 16(11):1412-9. PubMed ID: 17132404
[TBL] [Abstract][Full Text] [Related]
18. [A man with non alcoholic steatohepatitis].
Tran A; Anty R
Gastroenterol Clin Biol; 2003; 27(8-9):806-8. PubMed ID: 14586252
[No Abstract] [Full Text] [Related]
19. In search of an ideal biomarker for nonalcoholic fatty liver disease.
Bambha K; Yee HF
Am J Gastroenterol; 2008 Jun; 103(6):1380-2. PubMed ID: 18510615
[No Abstract] [Full Text] [Related]
20. Systemic levels of lipid peroxidation and its metabolic and dietary correlates in patients with nonalcoholic steatohepatitis.
Chalasani N; Deeg MA; Crabb DW
Am J Gastroenterol; 2004 Aug; 99(8):1497-502. PubMed ID: 15307867
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
